Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine and CBT4CBT for Cocaine Abuse in Methadone-Maintained Individuals
NCT00809835Phase 2Completed
- Sponsor
- Yale University
- Start
- Dec 2007
- Primary completion
- Jan 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of galantamine in cocaine dependence, sponsored by Yale University. Started Dec 2007; status: completed.
02
Drugs
galantamine
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT00809835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00809835.